When will determine the nature and extent of any type of cancer, oncologists will use a rubric or a system of "staging". This system holds a very important role in determining the proper cancer treatment program for patients. This is just one of the criteria of malignancy that are classified, the first is determined by the location or the location of the tumor and the second is determined by the structure of the provider.
The staging will help Oncology in determining how far the cancer has progressed and how the patient's malignancy will be actually treated.
Although there are actually three staging systems currently in use are different, but the trio is based on four main stages of mesothelioma, including:
Stage 1: Tumor confined to one region or organ and usually relatively small.
Stage 2: the size of the tumor has grown and has spread to one of the other organs.
Stage 3: the Tumor has spread to areas near or in the vicinity.
Stage 4: the Tumor has spread to distant parts of the body or "metastasis."
In stage 1, mesothelioma is localized and limited to one area of the body only.
Stage 1 Mesothelioma Prognosis
The main problems experienced by patients of mesothelioma is that historically, the conditions experienced by the patient is not detected until it reaches stage 3 mesothelioma stage 4, where at the time offers a choice in whatever form is overdue Besides doing palliative care.
One glimmer of hope is located in MESOMARK ™, a diagnostic test that has been approved by the FDA for use in the United States. This test has been developed by an American biotech firms and Japan reportedly able to detect biological signs of mesothelioma in the early moments of the most can be treated so that it has the best chance of being able to cure mesothelioma patients.
When the disease can be caught at stage 1, usually cancerous tissue can be removed by surgery mesothelioma; mesothelioma chemotherapy and mesothelioma radiation to follow up in getting rid of traces of malignancy.